|
US7176279B2
(en)
|
2000-06-28 |
2007-02-13 |
Palatin Technologies, Inc. |
Cyclic peptide compositions and methods for treatment of sexual dysfunction
|
|
EP1441750A4
(en)
|
2001-07-11 |
2006-10-18 |
Palatin Technologies Inc |
LINEAR AND CYCLIC PEPTIDES SPECIFIC TO THE MELANOCORTIN RECEPTOR
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
KR20060026011A
(ko)
|
2003-05-09 |
2006-03-22 |
노보 노르디스크 에이/에스 |
비만 치료용 펩티드
|
|
EP1644023A2
(en)
*
|
2003-06-19 |
2006-04-12 |
Eli Lilly And Company |
Melanocortin recptor 4(mc4) agonists and their uses
|
|
EP1644022A1
(en)
*
|
2003-06-19 |
2006-04-12 |
Eli Lilly And Company |
Uses of melanocortin-3 receptor (mc3r) agonist peptides
|
|
WO2005060985A1
(en)
*
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
|
JP2007530674A
(ja)
*
|
2004-03-29 |
2007-11-01 |
イーライ リリー アンド カンパニー |
連続注入によって投与されるメラノコルチン−4受容体(mc4r)アゴニストペプチドの使用
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
|
CN101203527A
(zh)
*
|
2005-05-31 |
2008-06-18 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
主链环化的促黑皮质素激素(αMSH)类似物
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
KR101687037B1
(ko)
|
2008-06-09 |
2016-12-15 |
팔라틴 테크놀로지스 인코포레이티드 |
성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
EP2348857B1
(en)
|
2008-10-22 |
2016-02-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
CA2761607C
(en)
|
2009-06-08 |
2018-09-04 |
Yi-Qun Shi |
Melanocortin receptor-specific peptides
|
|
EP2440572B1
(en)
|
2009-06-08 |
2017-04-05 |
Palatin Technologies, Inc. |
Lactam-bridged melanocortin receptor-specific peptides
|
|
UY32690A
(es)
|
2009-06-08 |
2011-01-31 |
Astrazeneca Ab |
Péptidos específicos para receptores de melanocortina
|
|
BR112012011780A2
(pt)
|
2009-11-23 |
2019-09-24 |
Palatin Technologies, Inc |
peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
|
|
JP5999702B2
(ja)
|
2009-11-23 |
2016-09-28 |
パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. |
メラノコルチン−1受容体特異的環状ペプチド
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
SG192941A1
(en)
|
2011-02-25 |
2013-09-30 |
Merck Sharp & Dohme |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
KR20150118158A
(ko)
|
2013-02-22 |
2015-10-21 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 비시클릭 화합물
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
EP3558298B1
(en)
|
2016-12-20 |
2026-03-11 |
Merck Sharp & Dohme LLC |
Antidiabetic spirochroman compounds
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
US11590209B2
(en)
|
2020-01-21 |
2023-02-28 |
Palatin Technologies, Inc. |
Use of bremelanotide in patients with controlled hypertension
|